Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry R Chobanian

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
ACS Medicinal Chemistry Letters|May 26, 2015
Improved Stability of Proline-Derived Direct Thrombin Inhibitors through Hydroxyl to Heterocycle ReplacementHarry R Chobanian, Barbara Pio, Yan Guo, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2017
The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diureticsHarry R Chobanian, Yan Guo, Barbara Pio, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Journal of Medicinal Chemistry|May 26, 2021
Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/NatriureticJinlong Jiang, Fa-Xiang Ding, Xiaoyan Zhou, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityHarry R Chobanian, Yan Guo, Ping Liu, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Y Chen, Christopher W Plummer, Dong Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2019
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMsBarbara Pio, Harry R Chobanian, Yan Guo, et al.
Journal of Medicinal Chemistry|March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's DiseaseElsie C Yu, Hua Zhou, Xin Yan, et al.
Bioorganic & Medicinal Chemistry|April 13, 2012
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerizationHarry R Chobanian, Yan Guo, Ping Liu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|May 26, 2015
Improved Stability of Proline-Derived Direct Thrombin Inhibitors through Hydroxyl to Heterocycle ReplacementHarry R Chobanian, Barbara Pio, Yan Guo, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2017
The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diureticsHarry R Chobanian, Yan Guo, Barbara Pio, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Journal of Medicinal Chemistry|May 26, 2021
Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/NatriureticJinlong Jiang, Fa-Xiang Ding, Xiaoyan Zhou, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityHarry R Chobanian, Yan Guo, Ping Liu, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Y Chen, Christopher W Plummer, Dong Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2019
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMsBarbara Pio, Harry R Chobanian, Yan Guo, et al.
Journal of Medicinal Chemistry|March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's DiseaseElsie C Yu, Hua Zhou, Xin Yan, et al.
Bioorganic & Medicinal Chemistry|April 13, 2012
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerizationHarry R Chobanian, Yan Guo, Ping Liu, et al.
Pageof 3